EP Plenary session - Short presentations

TRAN Committee - Vote on  update of EU rules on driving licence in order to improve road safety and get closer to zero deaths on EU roads by 2050

ENVI - Exchange of views with Dr Andrea AMMON, Director of the European Centre for Disease Prevention and Control (ECDC)

EP Plenary session - Packaging and packaging waste

EP Plenary session - Strengthening the CO2 emission performance targets for new heavy-duty vehicles

EP Plenary session - Type-approval of motor vehicles and engines with respect to their emissions and battery durability (Euro 7)

European Youth Hearing

ENVI - Vote on pesticides, carbon removals, glyphosate, CO2

EP Plenary session - Urban wastewater treatment

EP Plenary session - Commission statement - Medicine shortages and strategic healthcare autonomy in the EU

EP Plenary session - Ambiant air quality and cleaner air for Europe

EP Plenary session - Council and Commission statements - Towards a more disaster resilient EU - protecting people from extreme heatwaves, floods and forest fires

EP Plenary session - Voting session

EP Plenary session - COVID-19 pandemic: lessons learned and recommendations for the future

EP Plenary session - Nature restoration

During the plenary session of the European Parliament in Brussels (08-11 March 2021), MEPs debate on the programme for the Union's action in the field of health for the period 2021-2027 (“EU4Health Programme”): MEPs debate 1/3

Programme for the Union's action in the field of health for the period 2021-2027 (“EU4Health Programme”): MEPs debate 1/3

Members of the Committee on the Environment, Public Health and Food Safety (ENVI) and the Committee on Industry, Research and Energy (ITRE) have a joint hearing on "How to increase the capacity of COVID 19 vaccine production and improve delivery". Q&A with CEOs of the pharmaceutical industry Paul STOFFELS, Vice Chair of the Executive Committee and Chief Scientific Officer, Johnson & Johnson, Angela HWANG, President Global Biopharma, Pfizer Group, accompanied by Germain MORIN, VP Vaccines Supply Chain, Thomas TRIOMPHE, Executive Vice-President, Head of Sanofi Pasteur ,Suerie MOON, Co-Director, Global Health Centre, Graduate Institute of International and Development Studies, Geneva.

Joint hearing of the ENVI and ITRE Committee - "How to increase the capacity of COVID 19 vaccine production and improve delivery": Q&A with ENVI and ITRE Members and CEOs of the pharmaceutical industry

During the plenary session of the European Parliament in Brussels (08-11 February 2021), MEPs debate the state of play of the EU's COVID-19 Vaccination Strategy.

The state of play of the EU's COVID-19 vaccination strategy: MEPs debate (part 3)

During the plenary session of the European Parliament in Brussels (18-21 January 2021), MEPs debate on the EU global strategy on COVID-19 vaccinations. MEPs debate 3/3

EU global strategy on COVID-19 vaccinations: MEPs debate 3/3

In 2020, the coronavirus pandemic has put European health systems under enormous pressure and gaps have been showed up in the way public health emergencies are addressed. The EU is working on how to secure access to COVID-19 vaccines for all and the Parliament supported speedy authorisation of safe vaccines. Also, MEPs paved the way for an effective EU health programme, called "EU4Health" (for 2021-2027), which aims to fill these gaps. EU4Health's three main priorities are: tackling cross-border health threats; making medicines available and affordable; and strengthening health systems.

European Parliament Review 2020 - EU response to COVID-19

During the plenary session in Brussels (11-13 November 2020) MEPs debate the programme for the Union's action in the field of health for the period 2021-2027 (“EU4Health Programme”). MEPs debate (part 1)

Programme for the Union's action in the field of health for the period 2021-2027 (“EU4Health Programme”): MEPs debate (part 1)

During the plenary session (11-13/11/2020) of the European Parliament in Brussels, MEPs discussed and adopted its position on the legislative proposal for the so-called “EU4Health Programme”, which aims to increase EU capacities to help member states deal with health crises such as COVID-19.

Programme for the Union's action in the field of health for the period 2021-2027 (“EU4Health Programme”): extracts from the debate (12/11), from the vote and illustration shots

Public Hearing of Members of the Committee on the Environment, Public Health and Food Safety and the EP Committee on Industry, Research and Energy with Thomas TRIOMPHE, Executive Vice President, Sanofi Pasteur, Jean STEPHENNE, Chairman of the Supervisory Board, accompanied by Pierre Kemula, Chief Financial Officer, CureVac, Fergus SWEENEY, Head of Clinical Studies and Manufacturing Task Force, European Medicines Agency, Professor Robin SHATTOCK, Faculty of Medicine, Department of Infectious Disease, Imperial College London, Dr Sidney WONG, Director, Médecins Sans Frontières Access Campaign, Magdalena RODRIGUEZ de AZERO, Executive Director, Vaccines Europe, European Federation of Pharmaceutical Industries and Associations. Part 2 of 2 Q&A with ENVI and ITRE Members.

Public Hearing on How to secure access to COVID-19 vaccines for EU citizens: clinical trials, production and distribution challenges. Joint EP Committee ENVI and ITRE. 2/ 2 Q&A with ENVI and ITRE Members.

During the plenary session (14-17 September 2020) in Brussels, MEPs debate on the Covid-19: EU coordination of health assessments and risk classification and the consequences on Schengen and the single market. First round of political group leaders.

Covid-19: EU coordination of health assessments and risk classification and the consequences on Schengen and the single market: First round of political group leaders

Members of the EP Committee on the Environment, Public Health and Food Safety (ENVI) debate with Tedros Adhanom Ghebreyesus, Director-General of the World Health Organisation (WHO), during an exchange of views on the fight against COVID-19 and the global response to it. Increased coordination and cooperation at global level are crucial to better prevent and tackle pandemics. MEPs debate - part 1followed by the response by Tedros Adhanom Ghebreyesus.

Exchange of views with Tedros Adhanom Ghebreyesus, WHO Director General: MEPs debate (part 1) and response by Tedros Adhanom Ghebreyesus

Live Replay of the debate on Coronavirus outbreak, state of play and ensuring a coordinated European response to the health, economic and social impact during the plenary session in Brussels. The plenary session takes place in Brussels instead of Strasbourg because of concerns linked to the spread of the coronavirus. The session has been shortened to one day - Tuesday 10 March

Coronavirus outbreak, state of play and ensuring a coordinated European response to the health, economic and social impact: MEPs debate (part 3)

On 1st October 2019, Stella KYRIAKIDES, from Cyprus, Commissioner-designate for Health, is heard by the Committee on Environment, Public Health and Food Safety (ENVI) in association with the Committee on Agriculture and Rural Development (AGRI) of the European Parliament in Brussels to test her general competences, European commitment and specific expertise related to her portfolio. Second round of questions

48 tulosta